triazoles has been researched along with substance p in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilfillan, AM; Hope, WC; Patel, BJ; Welton, AF; Wiggan, GA | 1 |
| Eliakim, R; Karmeli, F; Okon, E; Rachmilewitz, D | 1 |
| Chandel, B; Deshpande, Y; Kaminski, DL; Longo, WE; Niehoff, M; Polities, G; Robinson, S; Vernava, AM | 1 |
| Greenlees, C; Medhurst, AD; Parsons, AA; Smith, SJ | 1 |
| Hargreaves, RJ; Hill, RG; Shepheard, SL; Williamson, DJ | 1 |
| Ball, R; Maliakal, A; Pye, PJ; Reamer, RA; Reider, PJ; Rossen, K; Tsou, NN; Volante, RP; Weissman, SA | 1 |
| Qin, XZ; Wu, A; Yuan, Y; Zhao, ZZ | 1 |
| Cicha, MZ; Hökfelt, T; Kopp, UC; Mulder, J; Smith, LA | 1 |
| Grosshans, M; Kiefer, F; Mutschler, J | 1 |
| Gehlert, DR; Iyengar, S; Kielbasa, W; Marek, G; Mozley, D; Peng, X; Tauscher, J; Vandenhende, F | 1 |
| Appenzeller, M; Bigliardi, P; Buclin, T; Grouzmann, E; Pannatier, A | 1 |
| Chen, X; Xiong, T; Yang, J; Yao, Z; Yu, M; Zhang, Y; Zhao, L; Zhou, Y | 1 |
| Billings, FT; Brown, NJ; Devin, JK; Nian, H; Pretorius, M; Yu, C | 1 |
| Aicher, B; Banères, JL; Blayo, AL; Damian, M; Denoyelle, S; Fehrentz, JA; Gagne, D; Günther, E; M'Kadmi, C; Maingot, M; Marie, J; Martinez, J; Mary, S; Müller, G; Sanchez, P; Schmidt, P; Teifel, M | 1 |
3 trial(s) available for triazoles and substance p
| Article | Year |
|---|---|
Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder.
Topics: Adult; Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Dose-Response Relationship, Drug; Gerbillinae; Humans; Male; Neurokinin-1 Receptor Antagonists; Paroxetine; Peptide Fragments; Pyridines; Radioligand Assay; Radionuclide Imaging; Receptors, Neurokinin-1; Stereotyped Behavior; Substance P; Treatment Outcome; Triazoles | 2010 |
Substance P-induced skin inflammation is not modulated by a single dose of sitagliptin in human volunteers.
Topics: Capsaicin; Carbonated Beverages; Cross-Over Studies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Edema; Erythema; Humans; Injections, Intradermal; Male; Pain; Pyrazines; Sitagliptin Phosphate; Skin; Substance P; Triazoles; Vasodilation | 2011 |
Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Cross-Over Studies; Dipeptidyl Peptidase 4; Double-Blind Method; Enalaprilat; Enzyme Inhibitors; Female; Heart Rate; Humans; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Peptidyl-Dipeptidase A; Pyrazines; Sitagliptin Phosphate; Substance P; Sympathetic Nervous System; Triazoles; Vascular Resistance | 2014 |
11 other study(ies) available for triazoles and substance p
| Article | Year |
|---|---|
Ro 19-3704 directly inhibits immunoglobulin E-dependent mediator release by a mechanism independent of its platelet-activating factor antagonist properties.
Topics: Animals; Azepines; Diterpenes; Ginkgolides; Glyceryl Ethers; Histamine Release; Humans; Immunoglobulin E; Inositol Phosphates; L-Lactate Dehydrogenase; Lactones; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rats; Substance P; Synovial Fluid; Thiazoles; Triazines; Triazoles; Tumor Cells, Cultured | 1990 |
Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer.
Topics: Animals; Azepines; Cimetidine; Ethanol; Gastric Acid; Gastric Mucosa; Gastrins; Hydroxyzine; In Vitro Techniques; Ketotifen; Leukotriene B4; Male; Mast Cells; Pepsin A; Peptide Fragments; Platelet Activating Factor; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; SRS-A; Substance P; Triazoles | 1991 |
Effect of platelet-activating factor and its antagonists on colonic dysmotility and tissue levels of colonic neuropeptides.
Topics: Alprazolam; Animals; Azepines; Colitis; Colon; Gastrointestinal Motility; In Vitro Techniques; Iodine Radioisotopes; Neuropeptides; Platelet Activating Factor; Rabbits; Substance P; Triazoles; Vasoactive Intestinal Peptide | 1994 |
Nitric oxide synthase inhibitors 7- and 6-nitroindazole relax smooth muscle in vitro.
Topics: Alprazolam; Animals; Azepines; Colitis; Colon; Gastrointestinal Motility; In Vitro Techniques; Iodine Radioisotopes; Neuropeptides; Platelet Activating Factor; Rabbits; Substance P; Triazoles; Vasoactive Intestinal Peptide | 1994 |
The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.
Topics: Analysis of Variance; Animals; Blood Proteins; Calcitonin Gene-Related Peptide; Disease Models, Animal; Dura Mater; Electric Stimulation; Injections, Intravenous; Lethal Dose 50; Male; Meningeal Arteries; Migraine Disorders; Neuromuscular Junction; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Substance P; Triazoles; Trigeminal Nuclei; Tryptamines; Vasodilation | 1997 |
Crystallization-induced diastereoselection: asymmetric synthesis of substance P inhibitors.
Topics: Animals; Antidepressive Agents; Crystallization; Humans; Hydroxylation; Molecular Structure; Morpholines; Stereoisomerism; Substance P; Triazoles | 2002 |
Novel rearrangements of an N-oxide degradate formed from oxidation of a morpholine acetal substance P antagonist.
Topics: Mass Spectrometry; Morpholines; Oxidation-Reduction; Substance P; Triazoles | 2004 |
Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of alpha1- and alpha2-adrenoceptors on renal sensory nerve fibers.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Fibers; Animals; Calcitonin Gene-Related Peptide; Dinoprostone; Indomethacin; Kidney; Male; Neurons, Afferent; Neurons, Efferent; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Substance P; Thiophenes; Triazoles | 2007 |
[A new pharmacological treatment option for alcohol dependence discovered in transnational study: neurokinin-1 receptor antagonist as a possible therapy for alcoholism?].
Topics: Adult; Alcohol Deterrents; Alcoholism; Animals; Double-Blind Method; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Neurokinin-1 Receptor Antagonists; Pyridines; Randomized Controlled Trials as Topic; Receptors, Neurokinin-1; Recurrence; Research; Substance P; Triazoles; Young Adult | 2008 |
Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
Topics: Aniline Compounds; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Gene Expression Regulation, Neoplastic; Humans; Inositol 1,4,5-Trisphosphate; Mammary Glands, Human; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurokinin-1 Receptor Antagonists; Phosphorylation; Receptors, Neurokinin-1; Reference Values; Substance P; Triazoles | 2013 |
New ligands of the ghrelin receptor based on the 1,2,4-triazole scaffold by introduction of a second chiral center.
Topics: Fluorescence Resonance Energy Transfer; Indoles; Inhibitory Concentration 50; Ligands; Receptors, Ghrelin; Structure-Activity Relationship; Substance P; Triazoles; Tryptophan | 2016 |